Biomarkers and surrogate endpoints
Executive Summary
FDA and the National Institutes of Health will sponsor a conference addressing "the interests of clinical investigators, therapeutic and diagnostic device developers and regulatory agency representatives in improving clinical trial design and evaluation practices." The conference will be held April 15-16 at Natcher Auditorium